$116.41
3.523.12%
At close: -
$116.41
0.000.00%
After Hours: 4:42 PM EDT
Comments
Loading...
Jazz Pharmaceuticals Stock Guidance | NASDAQ:JAZZ | Benzinga
Jazz Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $22.50 | $24.00 | $24.00 | $4.15B | $4.40B | $4.34B | Get Alert |
| 01/13/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | — | — | — | $4.00B | $4.10B | $4.04B | Get Alert |
| 12/16/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | — | — | — | $4.00B | $4.10B | $4.04B | Get Alert |
| 11/06/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $19.50 | $20.60 | $19.59 | $4.00B | $4.10B | $4.04B | Get Alert |
| 07/31/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $19.20 | $20.30 | $18.51 | $4.00B | $4.10B | $4.05B | Get Alert |
| 05/01/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $18.93 | $4.00B | $4.20B | $4.10B | Get Alert |
| 02/28/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $19.94 | $4.00B | $4.20B | $4.09B | Get Alert |
| 01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | — | — | — | $3.81B | $3.81B | $3.83B | Get Alert |
| 01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | — | — | — | $5.00B | $5.00B | — | Get Alert |
| 11/08/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $18.66 | $3.75B | $3.88B | $3.83B | Get Alert |
| 08/09/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $17.48 | $3.73B | $3.88B | $3.78B | Get Alert |
| 05/10/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $17.44 | $3.67B | $3.88B | $3.78B | Get Alert |
| 03/01/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $18.00 | $3.67B | $3.88B | $3.76B | Get Alert |
| 11/09/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $17.20 | $17.85 | $17.41 | $3.60B | $3.70B | $3.65B | Get Alert |
| 08/03/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.70 | $17.70 | $17.09 | $3.50B | $3.70B | $3.60B | Get Alert |
| 05/04/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | — | — | — | $3.50B | $3.70B | $3.58B | Get Alert |
| 03/01/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.00 | $17.00 | $17.47 | $3.46B | $3.66B | $3.64B | Get Alert |
| 01/10/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | — | — | — | $3.02B | $3.10B | $3.07B | Get Alert |
| 11/09/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.10 | $15.80 | $14.52 | $3.02B | $3.10B | $3.09B | Get Alert |
| 08/03/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $14.45 | $3.02B | $3.18B | $3.11B | Get Alert |
| 06/17/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $15.05 | $3.02B | $3.18B | $3.11B | Get Alert |
| 05/04/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.86 | $16.39 | $2.55B | $2.70B | $2.65B | Get Alert |
| 04/20/2021 | JAZZ | Jazz Pharmaceuticals | Q1 | 2021 | — | — | — | $605.00M | $610.00M | $613.95M | Get Alert |
| 02/23/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.85 | $16.78 | $2.55B | $2.70B | $2.56B | Get Alert |
| 01/12/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2020 | — | — | — | $2.32B | $2.38B | $2.34B | Get Alert |
| 11/02/2020 | JAZZ | Jazz Pharmaceuticals | FY | 2020 | $12.20 | $13.00 | $12.47 | $2.32B | $2.38B | $2.28B | Get Alert |
| 08/04/2020 | JAZZ | Jazz Pharmaceuticals | FY | 2020 | $11.90 | $13.00 | $11.73 | $2.23B | $2.33B | $2.20B | Get Alert |
FAQ
What is the most recent guidance for Jazz Pharmaceuticals (JAZZ)?
The most recent guidance for Jazz Pharmaceuticals (JAZZ) was reported on February 25, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $22.50 to $24.00, compared to the estimated EPS of $24.00. Additionally, Jazz Pharmaceuticals forecasted revenue between $4.15B and $4.40B for the quarter.
Browse guidance and forecast on all stocks.
